WWH.L

Worldwide Healthcare Trust Plc
Worldwide Healthcare Trust PLC - Transaction in Own Shares
1st November 2024, 17:08
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
For immediate release

01 November 2024

WORLDWIDE HEALTHCARE TRUST PLC

(the "Company")

MARKET PURCHASE OF COMPANY'S OWN SHARES

This notification is given, pursuant to the authority granted at an Annual
General Meeting of the Company held on 10 July 2024 to make market purchases of
the Company's own shares up to an aggregate maximum of 79,248,688.

The Company has purchased a market total of 151,341 Ordinary shares of 2.5p each
in the capital of the Company today at a price of 337.73 pence per share. These
shares will be held in treasury.

Following this transaction, the Company hereby notifies the market that the
resultant number of Ordinary shares held by the Company in treasury is
87,624,520 and the total number of Ordinary shares that the Company has in issue
is 601,665,200 so that the total number of voting rights in the Company
following the repurchase is 514,040,680.

The figure of 514,040,680 may be used by shareholders as the denominator for the
calculation by which they may determine if they are required to notify their
interest in, or change to their interest in, the Company under the FCA's
Disclosure Guidance and Transparency Rules.

For and on behalf of

Frostrow Capital LLP

Company Secretary

For further information, please contact:

Mark Pope

Frostrow Capital LLP

Tel: 020 3 0084913

This information was brought to you by Cision http://news.cision.com

TwitterFacebookLinkedIn